ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MACK Merrimack Pharmaceuticals Inc

15.1575
0.00 (0.00%)
27 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000139k0000
Operating Income -486k-504k-607k-447k-569k-531k-490k-669k
Pre Tax Income -478k-442k-489k-271k-391k-279k-228k-436k
Net Income -478k-442k-492k-271k-391k-279k-240k201.37M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -486k-504k-607k-447k-430k-531k-490k-669k
EBITDA -486k-504k-607k-447k-569k-531k-490k-669k
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 144.27M0000000
Operating Income -110.14M-95.77M-65.58M-27.27M-5.01M-2.62M-2.17M-2.18M
Pre Tax Income -153.52M-118.4M-68.46M-22.74M-3.01M-2.45M-1.54M-1.17M
Net Income -151.74M472.03M-40.51M-17.33M-3.03M-2.46M-1.54M-1.18M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.16535.376-3.036-1.295-0.226-0.183-0.109-0.082
EBIT -110.15M-84.65M-65.58M-21.99M-3.06M-2.47M-1.73M-2.04M
EBITDA -99.44M-90.55M-61.5M-25.04M-5.01M-2.62M-2.17M-2.18M

Your Recent History

Delayed Upgrade Clock